Customization of home closed-loop insulin delivery in adult patients with type 1 diabetes, assisted with structured remote monitoring: the pilot WP7 Diabeloop study

Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial

(2017) Firas H El-Khatib et al.   LANCET

Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol

(2017) Lia Bally et al.   BMJ Open

Hacking diabetes: DIY artificial pancreas systems

(2017) Conor Farrington   Lancet Diabetes & Endocrinology

Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study

(2017) Lia Bally et al.   Lancet Diabetes & Endocrinology

Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials

(2017) Alanna Weisman et al.   Lancet Diabetes & Endocrinology

Multinational Home Use of Closed-Loop Control Is Safe and Effective

(2016) Stacey M. Anderson et al.   DIABETES CARE

Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report: Table 1

(2016) David M. Maahs et al.   DIABETES CARE

Cybersecurity in Artificial Pancreas Experiments

(2015) Derek T. O'Keeffe et al.   Diabetes Technology & Therapeutics

Home Use of an Artificial Beta Cell in Type 1 Diabetes

(2015) Hood Thabit et al.   NEW ENGLAND JOURNAL OF MEDICINE

2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial

(2015) Jort Kropff et al.   Lancet Diabetes & Endocrinology

MD-Logic Overnight Control for 6 Weeks of Home Use in Patients With Type 1 Diabetes: Randomized Crossover Trial

(2014) Revital Nimri et al.   DIABETES CARE

Remote Glucose Monitoring in Camp Setting Reduces the Risk of Prolonged Nocturnal Hypoglycemia

(2013) Daniel J. DeSalvo et al.   Diabetes Technology & Therapeutics

The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients: A 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study)

(2011) G. Charpentier et al.   DIABETES CARE